Chairman of SpringHill Management, a private fund management company specialising in biotech and social venture capital investments. He is a partner of several social impact funds including Inqo Investments (South Africa), Springhill Equity Partners (US), Novastar Ventures (Kenya) and Garden Impact Investment (Singapore). He is the co-founder of the Transformational Business Network and is a trustee of the John Templeton Foundation and the Centre for Enterprise, Markets & Ethics (Oxford). He was the founder chairman of NCI Cancer Hospital (Malaysia) and the inventor of sheep monoclonal antibodies. He is a Pro-Chancellor of Surrey University (UK) and a Fellow of the Royal Society of Medicine (UK). He is a former board member of the Saracens Rugby Club and the APEC Life Science Innovation Forum

L. Gregory Jones is a leader and strategist whose creative engagement has helped institutions across the world to create transformational resource models. Greg’s global imagination has guided business, education, and religious leaders in Africa, Asia, Europe and the United States. Greg has a particular gift for incubating talent, ideas, and networks. He is passionate about re-shaping cultures within and across organizations and has coined the term 'traditioned innovation' to capture how he re-frames complex challenges to seize significant opportunities.

Greg currently serves as President of Belmont University in Nashville, TN. He is the former Dean of Duke Divinity School. Greg is a United Methodist elder in the Western North Carolina Conference.